Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | PTPN7 | P35236 | 3/20 | 0.42 |
| ▸ | HMGCR | P04035 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14759630 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL14759610 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL14759596 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL3697613 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL3199000 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL3695352 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL10631303 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL11579416 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL6745588 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 | |
| SCHEMBL3211092 | 1.00 | TSHR (0.57) | TSHRTHRBPTPN7HMGCRDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130129811-A1 | CATIONIC LIPID | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2013-05-23 | — | — | US | claimed |
| EP-2567952-A1 | CATIONIC LIPID | Kyowa Hakko Kirin Co., Ltd. (JP) | 2013-03-13 | — | — | EP | claimed |
| US-20130129811-A1 | CATIONIC LIPID | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| EP-2567952-A1 | CATIONIC LIPID | Kyowa Hakko Kirin Co., Ltd. (JP) | 2013-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130129811-A1 | CATIONIC LIPID | ACOX3, LPCAT1, ACOX1 | TSHR 1380/4885THRB 2181/4885PTPN7 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.